ISRCTN53570733已完成未知
Observational cohort study to evaluate the safety of agomelatine in standard medical practice in depressed patients: a prospective, observational (non interventional), international, multicentre cohort study
Institut de Recherches Internationales Servier (France)0 个研究点目标入组 1,484 人开始时间: 2010年8月27日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,484
研究概览
简要总结
2020 results in https://pubmed.ncbi.nlm.nih.gov/32729068/ (added 03/08/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32976677/ (added 28/09/2020)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Both genders patients aged at least 18 years or legal age of majority (without upper limit of age)
- •2. Initiated into agomelatine for their current depressive episode
- •3. Having signed an informed consent
排除标准
- •1. Having to stop an ongoing antidepressant with which they were treated with success for their depression
- •2. Already treated with another antidepressant that they wish to continue in addition to agomelatine
- •3. Planning to move during the 26 weeks of the follow-up
研究者
相似试验
已完成
3 期
Study to assess the safety and effectiveness of remdesivir in people with severe COVID-19COVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN15874265Gilead Sciences (United States)4,891
已完成
不适用
Comparing different types of jet ventilation during endobronchial ultrasound guided transbronchial needle aspiratioEBUS-TBNA +/- tumour biopsyCancerISRCTN58911367Medical University of Vienna90
已完成
不适用
ens replacement planning in patients with cataracts and corneal astigmatism using the iTrace programCataracts with corneal astigmatismEye DiseasesISRCTN94956424Shanxi Eye Hospital63
已完成
不适用
A study to assess the usefulness of combination of Vitamin D, magnesium and Vitamin B12 in older COVID-19 patientsCOVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN15324611SingHealth43
已完成
不适用
Is a mobile phone app delivering cognitive behavioural therapy effective at helping people quit smoking?Tobacco useMental and Behavioural DisordersISRCTN65853476Digital Therapeutics Inc.531